Health Enhancement Products Inc. Files International Patent Application to Protect Worldwide Rights to ProAlgaZyme.SCOTTSDALE, Ariz. -- Health Enhancement Products Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). : HEPI HEPI Higher Education Price Index HEPI Heavy Equipment Point of Impact (military paradrop) HEPI High Explosive Penetrating Incendiary ) today announced that it has filed an international patent application with the World Intellectual Property Organization (WIPO WIPO World Intellectual Property Organization WIPO World Intellectual Piracy Organization (satire website) WIPO Write in Poll Option WIPO Wing Information Protection Office (USAF) ), relating to relating to relate prep → concernant relating to relate prep → bezüglich +gen, mit Bezug auf +acc various methods of treatment using its phytopercolate, ProAlgaZyme. This application will be used to protect HEPI's worldwide rights relative to its ProAlgaZyme product. The patent application is for a method of treating or preventing a disease or disorder in a human by ingesting a phytopercolate, which is derived from mixtures including freshwater algae algae (ăl`jē) [plural of Lat. alga=seaweed], a large and diverse group of primarily aquatic plantlike organisms. These organisms were previously classified as a primitive subkingdom of the plant kingdom, the thallophytes (plants that , in this case being ProAlgaZyme. There are several treatment aspects of this patent application, including methods of treating immune system immune system Cells, cell products, organs, and structures of the body involved in the detection and destruction of foreign invaders, such as bacteria, viruses, and cancer cells. Immunity is based on the system's ability to launch a defense against such invaders. deficiency, type I and II diabetes, diseases related to the heart, cancer, arthritis, and most other diseases related to a deficient immune system. This patent application incorporates data from various clinical trials conducted to date. The patent application is also directed to methods of weight control using ProAlgaZyme. This patent filing is directed to the treatment of a variety of diseases including cardiovascular disease Cardiovascular disease Disease that affects the heart and blood vessels. Mentioned in: Lipoproteins Test cardiovascular disease , and diseases related to immune system deficient disorders. The patent filing is also directed to methods of treatment for weight loss, inflammatory disorders responsive to COX-2 inhibition and glucose control. The phytopercolate is an enzyme complex derived from a specific combination of microorganisms including freshwater algae. As humans' age and chronic disease processes progress, a deficiency of the enzymes that carry out the body's waste detoxification Detoxification Definition Detoxification is one of the more widely used treatments and concepts in alternative medicine. It is based on the principle that illnesses can be caused by the accumulation of toxic substances (toxins) in the body. and other processes may be experienced. A deficiency of enzymes can cause a chronic hyper-inflammatory state, and the disease process becomes much more complex. Without adequate enzymes in the body, the immune system and other metabolic processes become less efficient, making tissue repair slow and poorly replicated. Howard R. Baer, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Health Enhancement Products Inc., said, "Based on the preliminary results we have had with our various studies involving ProAlgaZyme, filing for this International patent application was important to protect, on a worldwide basis, methods of treatment using the product." About Health Enhancement Products Inc. Health Enhancement Products Inc. is a nutraceutical company engaged in the development of a supplementary health-enhancing product using only pure, all-natural ingredients. The company's sole product is ProAlgaZyme, a phytopercolate that is produced from an algae grown in 100% distilled water Noun 1. distilled water - water that has been purified by distillation H2O, water - binary compound that occurs at room temperature as a clear colorless odorless tasteless liquid; freezes into ice below 0 degrees centigrade and boils above 100 degrees centigrade; . The algae from which ProAlgaZyme is derived produces a protein, most likely as a means of protecting itself from exposure to outside disease and harmful bacteria. The protein solution is then drawn off, filtered, tested and bottled for consumption. In addition to supporting a compromised immune system, recent clinical studies indicate that ProAlgaZyme has potential weight loss properties. ProAlgaZyme has also been shown in a clinical study to have the potential to improve serum glucose management, when combined with a diet low in refined carbohydrates and a light exercise regimen. Except for any historical information, the matters discussed in this press release contain forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements involve risks and uncertainties. A number of factors could cause actual results to differ from those indicated in the forward-looking statements, including clinical trial results being different than the company's anecdotal results and the company's ability to fund its operations and market and sell its ProAlgaZyme product. Such statements are subject to a number of assumptions, risks and uncertainties. Readers are cautioned that such statements are not guarantees of future performance and that actual results or developments may differ materially from those set forth in the forward-looking statements. The company undertakes no obligation to publicly update or revise forward-looking statements, whether as a result of new information or otherwise. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion